JP2009537498A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009537498A5 JP2009537498A5 JP2009510536A JP2009510536A JP2009537498A5 JP 2009537498 A5 JP2009537498 A5 JP 2009537498A5 JP 2009510536 A JP2009510536 A JP 2009510536A JP 2009510536 A JP2009510536 A JP 2009510536A JP 2009537498 A5 JP2009537498 A5 JP 2009537498A5
- Authority
- JP
- Japan
- Prior art keywords
- crystal
- azd1152
- maleate
- cancer
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0609621.8A GB0609621D0 (en) | 2006-05-16 | 2006-05-16 | Novel co-crystal |
| PCT/GB2007/001771 WO2007132227A1 (en) | 2006-05-16 | 2007-05-14 | Maleate co-crystal of azd1152 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009537498A JP2009537498A (ja) | 2009-10-29 |
| JP2009537498A5 true JP2009537498A5 (enExample) | 2010-07-01 |
Family
ID=36637528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009510536A Pending JP2009537498A (ja) | 2006-05-16 | 2007-05-14 | Ａｚｄ１１５２のマレエート共結晶 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7625910B2 (enExample) |
| EP (1) | EP2027114A1 (enExample) |
| JP (1) | JP2009537498A (enExample) |
| KR (1) | KR20090009297A (enExample) |
| CN (1) | CN101448823A (enExample) |
| AR (1) | AR060963A1 (enExample) |
| AU (1) | AU2007251304A1 (enExample) |
| BR (1) | BRPI0712791A2 (enExample) |
| CA (1) | CA2650519A1 (enExample) |
| CL (1) | CL2007001388A1 (enExample) |
| EC (1) | ECSP088890A (enExample) |
| GB (1) | GB0609621D0 (enExample) |
| IL (1) | IL194862A0 (enExample) |
| MX (1) | MX2008014550A (enExample) |
| NO (1) | NO20084580L (enExample) |
| RU (1) | RU2008149242A (enExample) |
| SA (1) | SA07280243B1 (enExample) |
| TW (1) | TW200813026A (enExample) |
| UA (1) | UA95108C2 (enExample) |
| UY (1) | UY30351A1 (enExample) |
| WO (1) | WO2007132227A1 (enExample) |
| ZA (1) | ZA200809172B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE446093T1 (de) * | 2001-12-24 | 2009-11-15 | Astrazeneca Ab | Substituierte chinazolin-derivate als aurora- kinase inhibitoren |
| CA2526285A1 (en) * | 2003-05-15 | 2004-12-23 | Arqule, Inc. | Inhibitors of p38 and methods of using the same |
| CA2584368A1 (en) * | 2004-10-19 | 2006-04-27 | Arqule, Inc. | Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| WO2007123892A2 (en) * | 2006-04-17 | 2007-11-01 | Arqule Inc. | Raf inhibitors and their uses |
| CA2744713A1 (en) * | 2008-12-05 | 2010-06-10 | Arqule, Inc. | Raf inhibitors and their uses |
| NZ598758A (en) * | 2009-09-11 | 2013-12-20 | Amgen Inc | N-4 (-((3-(2-amino-4 pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer |
| GB201007286D0 (en) | 2010-04-30 | 2010-06-16 | Astex Therapeutics Ltd | New compounds |
| GB201020179D0 (en) | 2010-11-29 | 2011-01-12 | Astex Therapeutics Ltd | New compounds |
| GB201118656D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
| GB201118654D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
| GB201118675D0 (en) | 2011-10-28 | 2011-12-14 | Astex Therapeutics Ltd | New compounds |
| GB201118652D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
| GB201209613D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
| GB201209609D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
| GB201307577D0 (en) | 2013-04-26 | 2013-06-12 | Astex Therapeutics Ltd | New compounds |
| HUE034490T2 (en) | 2013-09-16 | 2018-02-28 | Astrazeneca Ab | Therapeutic polymer nanoparticles and methods for their preparation and use |
| JO3512B1 (ar) | 2014-03-26 | 2020-07-05 | Astex Therapeutics Ltd | مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز |
| BR112016022056B1 (pt) | 2014-03-26 | 2023-04-11 | Astex Therapeutics Limited | Combinação, composição farmacêutica, uso de uma combinação ou uma composição farmacêutica, e, produto farmacêutico |
| US10736900B2 (en) | 2014-03-26 | 2020-08-11 | Astex Therapeutics Ltd | Combinations of an FGFR inhibitor and an IGF1R inhibitor |
| TWI719960B (zh) | 2015-02-10 | 2021-03-01 | 英商阿斯迪克治療公司 | 新穎組成物 |
| US10478494B2 (en) | 2015-04-03 | 2019-11-19 | Astex Therapeutics Ltd | FGFR/PD-1 combination therapy for the treatment of cancer |
| HUE050567T2 (hu) | 2015-09-23 | 2020-12-28 | Janssen Pharmaceutica Nv | Triciklusos heterociklusok rák kezelésére |
| WO2017050865A1 (en) | 2015-09-23 | 2017-03-30 | Janssen Pharmaceutica Nv | Bi-heteroaryl substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE446093T1 (de) * | 2001-12-24 | 2009-11-15 | Astrazeneca Ab | Substituierte chinazolin-derivate als aurora- kinase inhibitoren |
| UA83814C2 (ru) * | 2002-12-24 | 2008-08-26 | Астразенека Аб | Производные фосфонооксихиназолина и их фармацевтическое применение |
-
2006
- 2006-05-16 GB GBGB0609621.8A patent/GB0609621D0/en not_active Ceased
-
2007
- 2007-05-10 TW TW096116652A patent/TW200813026A/zh unknown
- 2007-05-14 JP JP2009510536A patent/JP2009537498A/ja active Pending
- 2007-05-14 UA UAA200813934A patent/UA95108C2/ru unknown
- 2007-05-14 EP EP07732795A patent/EP2027114A1/en not_active Withdrawn
- 2007-05-14 RU RU2008149242/04A patent/RU2008149242A/ru not_active Application Discontinuation
- 2007-05-14 CN CNA2007800179575A patent/CN101448823A/zh active Pending
- 2007-05-14 MX MX2008014550A patent/MX2008014550A/es active IP Right Grant
- 2007-05-14 WO PCT/GB2007/001771 patent/WO2007132227A1/en not_active Ceased
- 2007-05-14 KR KR1020087029569A patent/KR20090009297A/ko not_active Withdrawn
- 2007-05-14 SA SA07280243A patent/SA07280243B1/ar unknown
- 2007-05-14 AU AU2007251304A patent/AU2007251304A1/en not_active Abandoned
- 2007-05-14 BR BRPI0712791-0A patent/BRPI0712791A2/pt not_active IP Right Cessation
- 2007-05-14 CA CA002650519A patent/CA2650519A1/en not_active Abandoned
- 2007-05-15 US US11/748,651 patent/US7625910B2/en not_active Expired - Fee Related
- 2007-05-15 CL CL2007001388A patent/CL2007001388A1/es unknown
- 2007-05-15 UY UY30351A patent/UY30351A1/es unknown
- 2007-05-16 AR ARP070102121A patent/AR060963A1/es not_active Application Discontinuation
-
2008
- 2008-10-23 IL IL194862A patent/IL194862A0/en unknown
- 2008-10-24 ZA ZA200809172A patent/ZA200809172B/xx unknown
- 2008-11-03 NO NO20084580A patent/NO20084580L/no not_active Application Discontinuation
- 2008-11-14 EC EC2008008890A patent/ECSP088890A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008149242A (ru) | Малеатный сокристалл azd1152 | |
| JP2011506330A5 (enExample) | ||
| JP2009502743A5 (enExample) | ||
| KR20090082284A (ko) | Ｂｃｌ 단백질과 결합 파트너와의 상호작용을 억제하는 화합물 및 방법 | |
| JP2011505356A5 (enExample) | ||
| JP2012532874A5 (enExample) | ||
| CA2606719A1 (en) | Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for producing the same | |
| JP2022502500A5 (enExample) | ||
| CN103635189A (zh) | 用于治疗癌症的含有cdk4/6抑制剂和pi3k抑制剂的联合治疗 | |
| RU2010119458A (ru) | 1,3,5-тризамещенное производное триазола | |
| JP2007504174A5 (enExample) | ||
| JP2012506872A5 (enExample) | ||
| FI3792254T3 (fi) | Kiteisiä metyylitioniniumkloridihydraatteja | |
| CA3119912A1 (en) | A crystalline spirocyclic compound inhibitor of tryptophan hydroxylase 1 (tph1) for treating diseases or disorders associated with peripheral serotonin | |
| JP2014530818A5 (enExample) | ||
| JP2012509279A5 (enExample) | ||
| CN103833626A (zh) | 西达本胺的晶型及其制备方法与应用 | |
| CN1511828A (zh) | 磺酰苯胺类衍生物及其医药用途 | |
| JP2011509306A5 (enExample) | ||
| JP2013523623A5 (enExample) | ||
| KR20120099212A (ko) | 트라마돌 및 콕시브의 공결정 | |
| JP2014141524A (ja) | ニコサミド（Ｎｉｃｏｕｓａｍｉｄｅ）化合物の五つの晶型、その製法やその薬物組合と用途 | |
| WO2009111948A1 (zh) | 3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基)哌啶-2,6-二酮及其衍生物的盐或盐的多晶型物及其制备和应用 | |
| JP2010540470A5 (enExample) | ||
| JP5341521B2 (ja) | タンパク質と結合パートナーとの相互作用を阻害するための化合物及び方法 |